(1)
Complementary-Therapy Use, Neuropathic Screening Status, and Quality of Life in Patients With Hypertension or Diabetes: A Pre–Post Observational Study. JPS 2026, 9 (3), 2688-2697. https://doi.org/10.36490/journal-jps.com.v9i3.1836.